标题
Humoral and cellular immunity against diverse SARS-CoV-2 variants
作者
关键词
-
出版物
Journal of Genetics and Genomics
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2023-10-19
DOI
10.1016/j.jgg.2023.10.003
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression
- (2023) Niklas Bobrovitz et al. LANCET INFECTIOUS DISEASES
- Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
- (2023) Hung Fu Tseng et al. Nature Communications
- Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis
- (2023) Caroline Stein et al. LANCET
- An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults
- (2023) Alicia T. Widge et al. Science Translational Medicine
- Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant
- (2023) Jumpei Ito et al. Nature Communications
- Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants
- (2023) Tomokazu Tamura et al. Nature Communications
- SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses
- (2022) Alexandra C. Walls et al. CELL
- T-cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals
- (2022) Vivek Naranbhai et al. CELL
- mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
- (2022) Wilfredo F. Garcia-Beltran et al. CELL
- SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron
- (2022) Alison Tarke et al. CELL
- SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
- (2022) Wanwisa Dejnirattisai et al. CELL
- Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants
- (2022) Emma K. Accorsi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity
- (2022) Bo Meng et al. NATURE
- Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron
- (2022) Juan Manuel Carreño et al. NATURE
- Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron
- (2022) Huiping Shuai et al. NATURE
- Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
- (2022) Rigel Suzuki et al. NATURE
- SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
- (2022) Peter J. Halfmann et al. NATURE
- Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants
- (2022) Kang Wang et al. NATURE
- mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
- (2022) Henning Gruell et al. NATURE MEDICINE
- Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant
- (2022) Yu Gao et al. NATURE MEDICINE
- Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants
- (2022) Hung Fu Tseng et al. NATURE MEDICINE
- Homologous and Heterologous Covid-19 Booster Vaccinations
- (2022) Robert L. Atmar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
- (2022) Heba N. Altarawneh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant
- (2022) Baisheng Li et al. Nature Communications
- Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants
- (2022) Timothy A. Bates et al. Science Immunology
- SARS-CoV-2 Omicron-neutralizing memory B-cells are elicited by two doses of BNT162b2 mRNA vaccine
- (2022) Ryutaro Kotaki et al. Science Immunology
- Differences in Clinical Characteristics Between Delta Variant and Wild-Type SARS-CoV-2 Infected Patients
- (2022) Zhenkui Hu et al. Frontiers in Medicine
- Humoral and cellular immune memory to four COVID-19 vaccines
- (2022) Zeli Zhang et al. CELL
- Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study
- (2022) Tommy Nyberg et al. LANCET
- Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden
- (2022) Peter Nordström et al. LANCET INFECTIOUS DISEASES
- Omicron infection enhances Delta antibody immunity in vaccinated persons
- (2022) Khadija Khan et al. NATURE
- Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory
- (2022) Kathleen M. Wragg et al. NATURE IMMUNOLOGY
- Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2
- (2022) Olha Puhach et al. NATURE MEDICINE
- Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
- (2022) Nick Andrews et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: Evidence from an outbreak in Yunnan, China, 2021
- (2022) Chao Ma et al. VACCINE
- Neutralizing activity of BBIBP-CorV vaccine-elicited sera against Beta, Delta and other SARS-CoV-2 variants of concern
- (2022) Xiaoqi Yu et al. Nature Communications
- Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes
- (2022) Jasmin Quandt et al. Science Immunology
- Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies
- (2022) Daichi Yamasoba et al. LANCET INFECTIOUS DISEASES
- BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
- (2022) Yunlong Cao et al. NATURE
- Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines
- (2022) John E. Bowen et al. SCIENCE
- Broadly neutralizing antibodies target the coronavirus fusion peptide
- (2022) Cherrelle Dacon et al. SCIENCE
- ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies
- (2022) Jun Siong Low et al. SCIENCE
- Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections
- (2022) Stijn P. Andeweg et al. Nature Communications
- Inactivated whole-virion vaccine BBV152/Covaxin elicits robust cellular immune memory to SARS-CoV-2 and variants of concern
- (2022) Rajesh Vikkurthi et al. Nature Microbiology
- Evasion of neutralizing antibody responses by the SARS-CoV-2 BA.2.75 variant
- (2022) Panke Qu et al. Cell Host & Microbe
- Long-primed germinal centres with enduring affinity maturation and clonal migration
- (2022) Jeong Hyun Lee et al. NATURE
- Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants
- (2022) Panke Qu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
- (2022) Young-Jun Park et al. SCIENCE
- Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2
- (2022) Panke Qu et al. Cell Host & Microbe
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
- (2021) Jennifer M. Dan et al. SCIENCE
- Early induction of functional SARS-CoV-2 specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients
- (2021) Anthony T. Tan et al. Cell Reports
- Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8+ T cells
- (2021) Anthony Kusnadi et al. Science Immunology
- No higher infectivity but immune escape of SARS-CoV-2 501Y.V2 variants
- (2021) Qianqian Li et al. CELL
- Maturation and persistence of the anti-SARS-CoV-2 memory B cell response
- (2021) Aurélien Sokal et al. CELL
- Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19
- (2021) Peter A. Szabo et al. IMMUNITY
- Emergence of a SARS-CoV-2 variant of concern with mutations in spike glycoprotein
- (2021) Houriiyah Tegally et al. NATURE
- Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
- (2021) Jianmin Zuo et al. NATURE IMMUNOLOGY
- Variation in SARS-CoV-2 outbreaks across sub-Saharan Africa
- (2021) Benjamin L. Rice et al. NATURE MEDICINE
- SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
- (2021) Constantinos Kurt Wibmer et al. NATURE MEDICINE
- Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model
- (2021) Fatima Amanat et al. mBio
- Prolonged evolution of the human B cell response to SARS-CoV-2 infection
- (2021) Mrunal Sakharkar et al. Science Immunology
- N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
- (2021) Matthew McCallum et al. CELL
- Antibody evasion by the P.1 strain of SARS-CoV-2
- (2021) Wanwisa Dejnirattisai et al. CELL
- Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant
- (2021) Venkata Viswanadh Edara et al. Cell Host & Microbe
- Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization
- (2021) Pengfei Wang et al. Cell Host & Microbe
- Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets
- (2021) Haley L. Dugan et al. IMMUNITY
- Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials
- (2021) Shilong Yang et al. LANCET INFECTIOUS DISEASES
- Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma
- (2021) Sandile Cele et al. NATURE
- Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
- (2021) Erik Volz et al. NATURE
- Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
- (2021) Delphine Planas et al. NATURE MEDICINE
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
- (2021) Laith J. Abu-Raddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization
- (2021) Guo-Lin Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Vivek Shinde et al. NEW ENGLAND JOURNAL OF MEDICINE
- Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study
- (2021) Mark S Graham et al. Lancet Public Health
- In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
- (2021) Dapeng Li et al. CELL
- Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
- (2021) Chang Liu et al. CELL
- Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines
- (2021) Yunlong Cao et al. CELL RESEARCH
- mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants
- (2021) Aurélien Sokal et al. IMMUNITY
- Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin
- (2021) Pragya D Yadav et al. JOURNAL OF TRAVEL MEDICINE
- Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac
- (2021) Yuxin Chen et al. LANCET INFECTIOUS DISEASES
- Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study
- (2021) Katherine A Twohig et al. LANCET INFECTIOUS DISEASES
- Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
- (2021) Delphine Planas et al. NATURE
- SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses
- (2021) Jackson S. Turner et al. NATURE
- BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants
- (2021) Jianying Liu et al. NATURE
- Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies
- (2021) Florian A. Lempp et al. NATURE
- Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants
- (2021) Zhiqiang Ku et al. NATURE
- Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
- (2021) Zijun Wang et al. NATURE
- Pan-Sarbecovirus Neutralizing Antibodies in BNT162b2-Immunized SARS-CoV-1 Survivors
- (2021) Chee-Wah Tan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination
- (2021) Dan H. Barouch et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
- (2021) Paul T. Heath et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characterization of a new SARS-CoV-2 variant that emerged in Brazil
- (2021) Masaki Imai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells
- (2021) Jose Mateus et al. SCIENCE
- Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies
- (2021) Marta Alenquer et al. PLoS Pathogens
- Integrated longitudinal immunophenotypic, transcriptional, and repertoire analyses delineate immune responses in patients with COVID-19
- (2021) Samuele Notarbartolo et al. Science Immunology
- Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study
- (2021) William M Souza et al. Lancet Microbe
- BNT162b2 mRNA Vaccine Effectiveness Given Confirmed Exposure: Analysis of Household Members of Coronavirus Disease 2019 Patients
- (2021) Sivan Gazit et al. CLINICAL INFECTIOUS DISEASES
- Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom Onset
- (2021) Jaclyn C. Law et al. JOURNAL OF IMMUNOLOGY
- Comparative Immunogenicity and Effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 Vaccines
- (2021) Vivek Naranbhai et al. JOURNAL OF INFECTIOUS DISEASES
- Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
- (2021) Salim S Abdool Karim et al. LANCET
- Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination
- (2021) Alice Cho et al. NATURE
- Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants
- (2021) Emanuele Andreano et al. NATURE
- Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation
- (2021) Akatsuki Saito et al. NATURE
- Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2
- (2021) Leo Swadling et al. NATURE
- An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease
- (2021) Yanchun Peng et al. NATURE IMMUNOLOGY
- Mechanisms of SARS-CoV-2 entry into cells
- (2021) Cody B. Jackson et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern
- (2021) Rishi R. Goel et al. SCIENCE
- Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar
- (2021) Adeel A. Butt et al. JAMA Internal Medicine
- The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape
- (2021) Dandan Tian et al. Frontiers in Immunology
- Immune signatures underlying post-acute COVID-19 lung sequelae
- (2021) I. S. Cheon et al. Science Immunology
- SARS-CoV-2 infection generates tissue-localized immunological memory in humans
- (2021) Maya M.L. Poon et al. Science Immunology
- Effectiveness of COVID-19 Vaccines against Delta (B.1.617.2) Variant: A Systematic Review and Meta-Analysis of Clinical Studies
- (2021) Ali Pormohammad et al. Vaccines
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
- (2020) Renhong Yan et al. SCIENCE
- Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
- (2020) Jasper Fuk-Woo Chan et al. Emerging Microbes & Infections
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant
- (2020) Maria Pachetti et al. Journal of Translational Medicine
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2
- (2020) Jianzhong Shi et al. SCIENCE
- Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding
- (2020) Tyler N. Starr et al. CELL
- Broad and differential animal ACE2 receptor usage by SARS-CoV-2
- (2020) Xuesen Zhao et al. JOURNAL OF VIROLOGY
- SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
- (2020) Nina Le Bert et al. NATURE
- Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens
- (2020) George Ueda et al. eLife
- Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
- (2020) Carolyn Rydyznski Moderbacher et al. CELL
- Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
- (2020) Luca Piccoli et al. CELL
- Human germinal centres engage memory and naive B cells after influenza vaccination
- (2020) Jackson S. Turner et al. NATURE
- Seasonal coronavirus protective immunity is short-lasting
- (2020) Arthur W. D. Edridge et al. NATURE MEDICINE
- COVID-19-neutralizing antibodies predict disease severity and survival
- (2020) Wilfredo F. Garcia-Beltran et al. CELL
- Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis
- (2020) SungA Bae et al. HEART
- PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19
- (2020) Min-Seok Rha et al. IMMUNITY
- Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2
- (2020) Jéromine Klingler et al. JOURNAL OF INFECTIOUS DISEASES
- Correlates of protection against SARS-CoV-2 in rhesus macaques
- (2020) Katherine McMahan et al. NATURE
- A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial
- (2020) Raffael Nachbagauer et al. NATURE MEDICINE
- Enhanced SARS-CoV-2 neutralization by dimeric IgA
- (2020) Zijun Wang et al. Science Translational Medicine
- IgA dominates the early neutralizing antibody response to SARS-CoV-2
- (2020) Delphine Sterlin et al. Science Translational Medicine
- T Follicular Helper Cell Biology: A Decade of Discovery and Diseases
- (2019) Shane Crotty IMMUNITY
- Evolutionary implications of a third lymphocyte lineage in lampreys
- (2013) Masayuki Hirano et al. NATURE
- Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
- (2013) J. Jardine et al. SCIENCE
- Infidelity of SARS-CoV Nsp14-Exonuclease Mutant Virus Replication Is Revealed by Complete Genome Sequencing
- (2010) Lance D. Eckerle et al. PLoS Pathogens
- Rapid cloning of high-affinity human monoclonal antibodies against influenza virus
- (2008) Jens Wrammert et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now